Intellipharmaceutics International Inc.
DelistedCIK 1474835fmd_0464BHVX9M9H94EAJS20F891JVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Dec 01, 2009 to Aug 31, 2023, 38 periods
Latest annual · FY2022
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (3)
- Net income
- (3)
- Free cash flow
- (1)
Latest quarter · Q2 FY2023
Millions- Total revenues
- 0
- Gross profit
- (1)
- Operating income
- (2)
- Net income
- (2)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- -73.4%
- Revenue, 5 yearsFY2017 to FY2022
- -58.8%
- Net income, 5 yearsFY2017 to FY2022
- n/m
Intellipharmaceutics International Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $65,728 | $0 | 20-F 2023-06-14 · proof | |
| Operating income | -$2.9 million | -$4.2 million | 20-F 2023-06-14 · proof | |
| Net income | -$2.9 million | -$5.1 million | 20-F 2023-06-14 · proof | |
| Cash from operating activities | -$1.4 million | -$2.5 million | 20-F 2023-06-14 · proof | |
| Free cash flow | -$1.4 million | -$2.5 million | 20-F 2023-06-14 · proof | |
| Total assets | $1.4 million | $2.1 million | -31.7% | 20-F 2023-06-14 · proof |
| Total liabilities | $12 million | $10.3 million | +17.1% | 20-F 2023-06-14 · proof |
| Cash and cash equivalents | $83,722 | $771,945 | -89.2% | 20-F 2023-06-14 · proof |
- What was Intellipharmaceutics International Inc.'s revenue in fiscal 2022?
- Intellipharmaceutics International Inc. reported revenue of $65,728 for fiscal 2022 (the year ended Nov 30, 2022), against $0 the year before. Source: the 20-F filed with the SEC on Jun 14, 2023. SEC
- What was Intellipharmaceutics International Inc.'s operating income in fiscal 2022?
- Intellipharmaceutics International Inc. reported operating income of -$2.9 million for fiscal 2022 (the year ended Nov 30, 2022), against -$4.2 million the year before. Source: the 20-F filed with the SEC on Jun 14, 2023. SEC
- What was Intellipharmaceutics International Inc.'s net income in fiscal 2022?
- Intellipharmaceutics International Inc. reported net income of -$2.9 million for fiscal 2022 (the year ended Nov 30, 2022), against -$5.1 million the year before. Source: the 20-F filed with the SEC on Jun 14, 2023. SEC
- What was Intellipharmaceutics International Inc.'s cash from operating activities in fiscal 2022?
- Intellipharmaceutics International Inc. reported cash from operating activities of -$1.4 million for fiscal 2022 (the year ended Nov 30, 2022), against -$2.5 million the year before. Source: the 20-F filed with the SEC on Jun 14, 2023. SEC
- What was Intellipharmaceutics International Inc.'s free cash flow in fiscal 2022?
- Intellipharmaceutics International Inc. reported free cash flow of -$1.4 million for fiscal 2022 (the year ended Nov 30, 2022), against -$2.5 million the year before. Source: the 20-F filed with the SEC on Jun 14, 2023. SEC
- What are Intellipharmaceutics International Inc.'s total assets?
- As of Nov 30, 2022, Intellipharmaceutics International Inc. reported total assets of $1.4 million, against $2.1 million a year earlier (-31.7%). Source: the 20-F filed with the SEC on Jun 14, 2023. SEC
- What are Intellipharmaceutics International Inc.'s total liabilities?
- As of Nov 30, 2022, Intellipharmaceutics International Inc. reported total liabilities of $12 million, against $10.3 million a year earlier (+17.1%). Source: the 20-F filed with the SEC on Jun 14, 2023. SEC
- What are Intellipharmaceutics International Inc.'s cash and cash equivalents?
- As of Nov 30, 2022, Intellipharmaceutics International Inc. reported cash and cash equivalents of $83,722, against $771,945 a year earlier (-89.2%). Source: the 20-F filed with the SEC on Jun 14, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1474835&period_type=annual&limit=5"Information only, not investment advice.